Successful re-introduction of lamotrigine after initial rash

Seizure

Volumn 9, Issue 4, 2000, Pages 282-286

  Besag, F M C ^a   Ng, G Y T ^b   Pool, F ^a  

^a St Piers Lingfield   (United Kingdom)

^b EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Escalation; Lamotrigine; Rash; Re introduction; Slow

Indexed keywords

AMOXICILLIN; CARBAMAZEPINE; ETHOSUXIMIDE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ARTICLE; BLISTER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HUMAN; MALE; MUCOSA; PRIORITY JOURNAL; RASH; SKIN EXFOLIATION;

EID: 0033933292     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2000.0394     Document Type: Article

References (13)

1. Messenheimer J. A. Rash in adult and pediatric patients treated with lamotrigine. Canadian Journal of Neurological Sciences. 25:1998;S14-S18.
2. Steiner T. J., Findley L. J., Yuen A. W. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia. 17:1997;109-112.
3. Schlumberger E., Chavez F., Palacios L., Rey E., Pajot N., Dulac O. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia. 35:1994;359-367.
4. Chaffin J. J., Davis S. M. Suspected lamotrigine induced toxic epidermal necrolysis. The Annals of Pharmacotherapy. 3:1997;720-723.
5. Sterker M., Berrouschet J., Schneider D. Fatal course of toxic epidermal necrolysis under treatment with lamotrigine. International Journal of Clinical Pharmacology Therapeutics. 33:1995;595-597.
6. Eames P. Adverse reactions to carbamazepine managed by desensitisation. Lancet. 1:1989;509-510.
7. Smith H., Newton R. Adverse reactions to carbamazepine managed by desensitisation. Lancet. 1:1985;753.
8. Chadwick D., Shaw M. D., Foy P., Rawlins M. D., Turnbull D. M. Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. Journal of Neurology, Neurosurgery and Psychiatry. 47:1984;642-644.
9. Tavernor S. J., Wong I. C. K., Newton R., Brown S. W. Rechallenge with lamotrigine after initial rash. Seizure. 4:1995;67-71.
10. Schaub J. E. M., Williamson P. J., Barnes E. W., Trewby P. N. Multisystem adverse reaction to lamotrigine. Lancet. 344:1994;481.
11. Makin A. J., Pitt S., Williams R., Duncan J. S. Drug points-Fulminant hepatic failure induced by lamotrigine. British Medical Journal. 311:1995;292.
12. Besag F. M. C., McShane A., Neville B. G. R., Robinson R. O. Factors associated with serious skin reactions in children aged 12 years and under taking lamotrigine. Developmental Medicine and Child Neurology. 41:1999;847-848.
13. Guberman A. H., Besag F. M. C., Brodie M. J. et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia. 40:1999;985-991.